Inhibiting TNF-mediated signaling: A novel therapeutic paradigm for androgen independent prostate cancer

Apoptosis

Volumn 15, Issue 2, 2010, Pages 153-161

  Srinivasan, Sowmyalakshmi ^a   Kumar, Raj ^a   Koduru, Srinivas ^a   Chandramouli, Aaditya ^a   Damodaran, Chendil ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; Caspases; Death receptors; Psoralidin; TNF signaling

Indexed keywords

DEATH RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PSORALIDIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANDROGENS; ANIMALS; APOPTOSIS; BENZOFURANS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; COUMARINS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; MICE; NF-KAPPA B; PROSTATIC NEOPLASMS; RECEPTORS, DEATH DOMAIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77949270814     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-009-0416-9     Document Type: Article

References (36)

1. D Tracey L Klareskog EH Sasso JG Salfeld PP Tak 2008 Tumor necrosis factor antagonist mechanisms of action: a comprehensive review Pharmacol Ther 117 244 279 10.1016/j.pharmthera.2007.10.001 1:CAS:528:DC%2BD1cXhtV2it74%3D 18155297
2. A Ferrajoli MJ Keating T Manshouri, et al. 2002 The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia Blood 100 1215 1219 1:CAS:528:DC%2BD38Xmt12it7Y%3D 12149200
3. PW Szlosarek MJ Grimshaw H Kulbe, et al. 2006 Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium Mol Cancer Ther 5 382 390 10.1158/1535-7163.MCT-05-0303 1:CAS:528: DC%2BD28XhvVelsLk%3D 16505113
4. G Sethi B Sung BB Aggarwal 2008 TNF: a master switch for inflammation to cancer Front Biosci 13 5094 5107 10.2741/3066 1:CAS:528:DC%2BD1cXnsVOjtL4%3D 18508572 (Pubitemid 351599660)
5. J Hu H Nakano H Sakurai NH Colburn 2004 Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells Carcinogenesis 25 1991 2003 10.1093/carcin/bgh198 1:CAS:528:DC%2BD2cXnvVOqtrw%3D 15192014 (Pubitemid 39405920)
6. CH Arnott KA Scott RJ Moore, et al. 2002 Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway Oncogene 21 4728 4738 10.1038/sj.onc.1205588 1:CAS:528:DC%2BD38XltVOmurc%3D 12101411 (Pubitemid 34879448)
7. B Yan H Wang ZN Rabbani, et al. 2006 Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation Cancer Res 66 11565 11570 10.1158/0008-5472.CAN-06-2540 1:CAS:528:DC%2BD28XhtlagurvK 17178846 (Pubitemid 46094163)
8. N Babbar RA Casero Jr 2006 Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis Cancer Res 66 11125 11130 10.1158/0008-5472.CAN-06-3174 1:CAS:528:DC%2BD28Xht1KnsL7M 17145855 (Pubitemid 46009938)
9. S Nagata P Golstein 1995 The Fas death factor Science 267 1449 1456 10.1126/science.7533326 1:CAS:528:DyaK2MXktlClt7w%3D 7533326
10. A Devin A Cook Y Lin Y Rodriguez M Kelliher Z Liu 2000 The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation Immunity 12 419 429 10.1016/S1074-7613(00) 80194-6 1:CAS:528:DC%2BD3cXivFyrsbs%3D 10795740
11. ZG Liu J Han 2001 Cellular responses to tumor necrosis factor Curr Issues Mol Biol 3 79 90 11719971
12. Y Lin A Devin Y Rodriguez ZG Liu 1999 Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis Genes Dev 13 2514 2526 10.1101/gad.13.19.2514 1:CAS:528:DyaK1MXmvFOit78%3D 10521396 (Pubitemid 29489643)
13. BB Aggarwal G Sethi V Baladandayuthapani S Krishnan S Shishodia 2007 Targeting cell signaling pathways for drug discovery: an old lock needs a new key J Cell Biochem 102 580 592 10.1002/jcb.21500 1:CAS:528:DC%2BD2sXht1SjsbnO 17668425 (Pubitemid 47557413)
14. N Larmonier D Cathelin C Larmonier, et al. 2007 The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model Exp Cell Res 313 2345 2355 10.1016/j.yexcr.2007.03.027 1:CAS:528:DC%2BD2sXmsFyrtr4%3D 17466973 (Pubitemid 46891466)
15. N Senzer S Mani A Rosemurgy, et al. 2004 TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors J Clin Oncol 22 592 601 10.1200/JCO.2004.01.227 1:CAS:528:DC%2BD2cXpsVajs70%3D 14726502 (Pubitemid 41095061)
16. A Krippner-Heidenreich I Grunwald G Zimmermann, et al. 2008 Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity J Immunol 180 8176 8183 1:CAS:528:DC%2BD1cXntVeltr0%3D 18523283
17. R Kumar S Srinivasan S Koduru, et al. 2009 Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells Cancer Prev Res (Phila Pa) 2 234 243
18. D Chendil RS Ranga D Meigooni S Sathishkumar MM Ahmed 2004 Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 Oncogene 23 1599 1607 10.1038/sj.onc.1207284 1:CAS:528:DC%2BD2cXhsFOht7g%3D 14985701 (Pubitemid 38406523)
19. S Sowmyalakshmi EAM Nur MA Akbarsha S Thirugnanam J Rohr D Chendil 2005 Investigation on Semecarpus Lehyam-a Siddha medicine for breast cancer Planta 220 910 918 10.1007/s00425-004-1405-4 1:CAS:528:DC%2BD2MXjtl2ltbo%3D 15517350 (Pubitemid 40599999)
20. T Liu LY Wu JK Choi CE Berkman 2009 In vitro targeted photodynamic therapy with a pyropheophorbide-a conjugated inhibitor of prostate-specific membrane antigen Prostate 69 585 594 10.1002/pros.20909 1:CAS:528: DC%2BD1MXlslCiu74%3D 19142895
21. S Srinivasan RS Ranga R Burikhanov SS Han D Chendil 2007 Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells Cancer Res 67 246 253 10.1158/0008-5472.CAN-06-2430 1:CAS:528:DC%2BD2sXisFSmsg%3D%3D 17185378 (Pubitemid 46142781)
22. S Srinivasan S Koduru R Kumar G Venguswamy N Kyprianou C Damodaran 2009 Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells Int J Cancer 125 961 967 10.1002/ijc.24419 1:CAS:528:DC%2BD1MXnsFeltbs%3D 19384950
23. N Rabiau P Dechelotte L Guy, et al. 2009 Immunohistochemical staining of mucin 1 in prostate tissues In Vivo 23 203 207 19414404
24. GS Salvesen CS Duckett 2002 IAP proteins: blocking the road to death's door Nat Rev Mol Cell Biol 3 401 410 10.1038/nrm830 1:CAS:528: DC%2BD38XltlartL4%3D 12042762 (Pubitemid 34685698)
25. EC de Bruin JP Medema 2008 Apoptosis and non-apoptotic deaths in cancer development and treatment response Cancer Treat Rev 34 737 749 10.1016/j.ctrv.2008.07.001 18722718
26. BP Eckelman GS Salvesen 2006 The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases J Biol Chem 281 3254 3260 10.1074/jbc.M510863200 1:CAS:528:DC%2BD28XhtFSmsrk%3D 16339151 (Pubitemid 43845937)
27. Y Chen YT Cheung LD Kong, et al. 2008 Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia Life Sci 82 1117 1121 10.1016/j.lfs.2008.03.014 1:CAS:528:DC%2BD1cXlslait7w%3D 18445497
28. P Pahari J Rohr 2009 Total synthesis of psoralidin, an anticancer natural product J Org Chem 74 2750 2754 10.1021/jo8025884 1:CAS:528: DC%2BD1MXisFansrw%3D 19254011
29. NA Khatune ME Islam ME Haque P Khondkar MM Rahman 2004 Antibacterial compounds from the seeds of Psoralea corylifolia Fitoterapia 75 228 230 10.1016/j.fitote.2003.12.018 1:CAS:528:DC%2BD2cXitFKktro%3D 15030932 (Pubitemid 38353091)
30. EM Gravallese DL Galson SR Goldring PE Auron 2001 The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption Arthritis Res 3 6 12 10.1186/ar134 1:CAS:528:DC%2BD3MXhslWjs7s%3D 11178122 (Pubitemid 32223800)
31. AV Gasparian YJ Yao D Kowalczyk, et al. 2002 The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells J Cell Sci 115 141 151 1:CAS:528:DC%2BD38XovVeitA%3D%3D 11801732
32. M Saleem MH Kweon JM Yun, et al. 2005 A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model Cancer Res 65 11203 11213 10.1158/0008-5472.CAN-05-1965 1:CAS:528:DC%2BD2MXht1KjsrvP 16322271 (Pubitemid 41713392)
33. XX Wu O Ogawa Y Kakehi 2004 TRAIL and chemotherapeutic drugs in cancer therapy Vitam Horm 67 365 383 10.1016/S0083-6729(04)67019-1 1:CAS:528: DC%2BD2cXltlKgtLk%3D 15110186 (Pubitemid 39753671)
34. WC Earnshaw LM Martins SH Kaufmann 1999 Mammalian caspases: structure, activation, substrates, and functions during apoptosis Annu Rev Biochem 68 383 424 10.1146/annurev.biochem.68.1.383 1:CAS:528:DyaK1MXlvFajsb0%3D 10872455 (Pubitemid 29449198)
35. C Jiang Z Wang H Ganther J Lu 2001 Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells Cancer Res 61 3062 3070 1:CAS:528:DC%2BD3MXivFGqsLw%3D 11306488
36. EA Slee MT Harte RM Kluck, et al. 1999 Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner J Cell Biol 144 281 292 10.1083/jcb.144.2.281 1:CAS:528:DyaK1MXmslyqsA%3D%3D 9922454 (Pubitemid 29066031)